Bovari-Biri J, Miskei J, Kover Z, Steinerbrunner-Nagy A, Kardos K, Maroti P
Cells. 2025; 14(2).
PMID: 39851573
PMC: 11763601.
DOI: 10.3390/cells14020145.
Souche C, Fouillet J, Rubira L, Donze C, Deshayes E, Fersing C
Int J Mol Sci. 2024; 25(1).
PMID: 38203632
PMC: 10779041.
DOI: 10.3390/ijms25010462.
Tanveer N, Hussein S, Pingili S, Makkena V, Jaramillo A, Awosusi B
Cureus. 2023; 15(9):e45270.
PMID: 37846237
PMC: 10576843.
DOI: 10.7759/cureus.45270.
Meneghetti L, Perry K
JFMS Open Rep. 2023; 9(2):20551169231183752.
PMID: 37581124
PMC: 10423456.
DOI: 10.1177/20551169231183752.
Stapleton J, Ard J, Beavers D, Cogdill L, Fernandez A, Howard M
Contemp Clin Trials Commun. 2023; 34:101181.
PMID: 37456507
PMC: 10344650.
DOI: 10.1016/j.conctc.2023.101181.
Estimated Phytate Intake Is Associated with Bone Mineral Density in Mediterranean Postmenopausal Women.
Sanchis P, Prieto R, Konieczna J, Grases F, Abete I, Salas-Salvado J
Nutrients. 2023; 15(7).
PMID: 37049631
PMC: 10097286.
DOI: 10.3390/nu15071791.
Multimodal and Multiscale Characterization of the Bone-Bacteria Interface in a Case of Medication-Related Osteonecrosis of the Jaw.
Micheletti C, DiCecco L, Wexell C, Binkley D, Palmquist A, Grandfield K
JBMR Plus. 2022; 6(12):e10693.
PMID: 36530189
PMC: 9751653.
DOI: 10.1002/jbm4.10693.
Effect of phytate on hypercalciuria secondary to bone resorption in patients with urinary stones: pilot study.
Guimera J, Martinez A, Bauza J, Sanchis P, Pieras E, Grases F
Urolithiasis. 2022; 50(6):685-690.
PMID: 36087116
PMC: 9584984.
DOI: 10.1007/s00240-022-01357-8.
Understanding the Protective Effect of Phytate in Bone Decalcification Related-Diseases.
Sanchis P, Lopez-Gonzalez A, Costa-Bauza A, Busquets-Cortes C, Riutord P, Calvo P
Nutrients. 2021; 13(8).
PMID: 34445019
PMC: 8400850.
DOI: 10.3390/nu13082859.
Postoperative bisphosphonate do not significantly alter the fusion rate after lumbar spinal fusion: a meta-analysis.
Mei J, Song X, Guan X, Wu D, Wang J, Liu Q
J Orthop Surg Res. 2021; 16(1):284.
PMID: 33926494
PMC: 8082634.
DOI: 10.1186/s13018-021-02444-z.
A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation.
Coffman A, Basta-Pljakic J, Guerra R, Ebetino F, Lundy M, Majeska R
JBMR Plus. 2021; 5(4):e10476.
PMID: 33869992
PMC: 8046044.
DOI: 10.1002/jbm4.10476.
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.
Raterman H, Bultink I, Lems W
Drugs. 2019; 79(10):1065-1087.
PMID: 31201710
DOI: 10.1007/s40265-019-01145-6.
Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair: A review.
Qayoom I, Raina D, Sirka A, Tarasevicius S, Tagil M, Kumar A
Bone Joint Res. 2018; 7(10):548-560.
PMID: 30464835
PMC: 6215244.
DOI: 10.1302/2046-3758.710.BJR-2018-0015.R2.
New agents in the Treatment of Myeloma Bone Disease.
Ring E, Lawson M, Snowden J, Jolley I, Chantry A
Calcif Tissue Int. 2017; 102(2):196-209.
PMID: 29098361
PMC: 5805798.
DOI: 10.1007/s00223-017-0351-7.
An Evaluative History of Bisphosphonate Drugs: Dual Physiologic Effects of Pyrophosphate as Inspiration for a Novel Pharmaceutical Class.
Hinshaw W, DeLong A
J Osteoporos. 2016; 2016:1426279.
PMID: 27800209
PMC: 5069370.
DOI: 10.1155/2016/1426279.
Localization of Minodronate in Mouse Femora Through Isotope Microscopy.
Hongo H, Sasaki M, Kobayashi S, Hasegawa T, Yamamoto T, Tsuboi K
J Histochem Cytochem. 2016; 64(10):601-22.
PMID: 27666429
PMC: 5037504.
DOI: 10.1369/0022155416665577.
Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?.
Charehbili A, Fontein D, Kroep J, Liefers G, Nortier J, van de Velde C
J Clin Med. 2015; 2(4):188-200.
PMID: 26237143
PMC: 4470143.
DOI: 10.3390/jcm2040188.
Bisphosphonates and their influence on fracture healing: a systematic review.
Molvik H, Khan W
Osteoporos Int. 2015; 26(4):1251-60.
PMID: 25572046
DOI: 10.1007/s00198-014-3007-8.
Bone safety with risedronate: histomorphometric studies at different dose levels and exposure.
Recker R, Ste-Marie L, Chavassieux P, McClung M, Lundy M
Osteoporos Int. 2014; 26(1):327-37.
PMID: 25304456
DOI: 10.1007/s00198-014-2850-y.
Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry.
Raccor B, Sun J, Lawrence R, Li L, Zhang H, Somerman M
J Chromatogr B Analyt Technol Biomed Life Sci. 2013; 935:54-60.
PMID: 23954589
PMC: 3869204.
DOI: 10.1016/j.jchromb.2013.07.019.